Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145301
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2005-09-01
Brief Title:
52 Week International Multi-center Randomized Double-blind Double-dummy Parallel-group Clinical Trial to Compare Retention on Treatment Safety Tolerability Efficacy of Lumiracoxib 100 mg od Lumiracoxib 100 mg Bid Celecoxib 200 mg od in Pts With Primary OA of Hip Knee Hand or Spine
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CCOX189A2369
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None